Phase 2 Overweight trials recruiting now

All Overweight trials, every phase

Other phases for Overweight

Phase 2 Overweight trials

• A Master Protocol Study (LY900038) of Multiple Intervention-Specific-Appendices (ISAs) in Adult Participants With Obesity or Overweight
  NCT06143956 · Phase: Phase 2 · Ages: 18 Years to 75 Years · Sex: All (male and female) · 56 locations
• A Research Study on How Well Different Doses of the Medicine UBT251 Help People Living With Overweight or Obesity
  NCT07395687 · Phase: Phase 2 · Ages: 18 Years to 65 Years · Sex: All (male and female) · 3 locations
• A Study of Macupatide (LY3532226) and Eloralintide (LY3841136), Alone or in Combination, in Adults With Obesity or Overweight and With Type 2 Diabetes
  NCT07215559 · Phase: Phase 2 · Ages: 18 Years to 75 Years · Sex: All (male and female) · 42 locations
• A Study of PF-08653945 and PF-08653944 in Adults With Overweight or Obesity (SOLIS-1)
  NCT07575932 · Phase: Phase 2 · Ages: 18 Years and older · Sex: All (male and female) · 65 locations
• A Study to Investigate Weight Management With Macupatide and Eloralintide, Alone or in Combination, in Adult Participants With Obesity or Overweight
  NCT07589608 · Phase: Phase 2 · Ages: 18 Years to 75 Years · Sex: All (male and female) · 40 locations
• A Study to Test Whether BI 3034701 Helps People to Lose Weight Who Live With Obesity or Overweight
  NCT07662122 · Phase: Phase 2 · Ages: 18 Years to 74 Years · Sex: All (male and female) · 55 locations
• Efficacy and Safety of Oral KAI-7535 in Adult Participants Living With Obesity or Overweight With at Least 1 Weight-Related Comorbidity
  NCT07497880 · Phase: Phase 2 · Ages: 18 Years to 75 Years · Sex: All (male and female) · 36 locations
• Safety and Efficacy of ABBV-295 in Adults With Obesity or Overweight With Weight-Related Comorbidities
  NCT07752979 · Phase: Phase 2 · Ages: 18 Years to 75 Years · Sex: All (male and female) · 40 locations
• Semaglutide for Post-Smoking Cessation Weight Management
  NCT06173778 · Phase: Phase 2 · Ages: 18 Years to 75 Years · Sex: All (male and female) · 2 locations
• Study to Evaluate the Efficacy and Safety of KDS2010 in Overweight or Obese Patients
  NCT07009171 · Phase: Phase 2 · Ages: 18 Years and older · Sex: All (male and female) · 3 locations
• Taxi ROADmAP (Realizing Optimization Around Diet And Physical Activity)
  NCT05770570 · Phase: Phase 2 · Ages: 21 Years and older · Sex: All (male and female) · 1 location
• Tirzepatide: Reversal of Lipotoxicity and Adipose Tissue Dysfunction in Humans With Overweight/Obesity
  NCT05912621 · Phase: Phase 2 · Ages: 18 Years to 70 Years · Sex: All (male and female) · 1 location

Common questions

What does Phase 2 mean?

See how clinical trials work.

Is this list complete?

No. For the full record, search ClinicalTrials.gov.